Get the Stockscreener App
2.06
0.24%
-0.005
Hillevax Inc stock is traded at $2.06, with a volume of 480.17K.
It is down -0.24% in the last 24 hours and down -2.37% over the past month.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
See More
Previous Close:
$2.065
Open:
$2.07
24h Volume:
480.17K
Relative Volume:
1.00
Market Cap:
$103.29M
Revenue:
-
Net Income/Loss:
$-123.57M
P/E Ratio:
-0.6776
EPS:
-3.04
Net Cash Flow:
$-97.53M
1W Performance:
-0.96%
1M Performance:
-2.37%
6M Performance:
+12.57%
1Y Performance:
+7.29%
1-Day Range:
$2.06
$2.08
1-Week Range:
$2.05
$2.10
52-Week Range:
$1.34
$2.17
Hillevax Inc Stock (HLVX) Company Profile
Name
Hillevax Inc
Sector
Industry
Phone
(617) 213-5054
Address
321 HARRISON AVE, SUITE 500, BOSTON
Compare HLVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
2.06 | 103.26M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-09-24 | Downgrade | Stifel | Buy → Hold |
| Jul-08-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-23 | Initiated | H.C. Wainwright | Buy |
View All
Hillevax Inc Stock (HLVX) Latest News
What data driven models say about HilleVax Inc.’s futureJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - Newser
HilleVax Inc. stock trend outlook and recovery pathQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders - MarketScreener
HilleVax Inc. stock trend forecastGap Up & Scalable Portfolio Growth Ideas - Newser
How to build a custom watchlist for HilleVax Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser
Using data filters to optimize entry into HilleVax Inc.2025 Market Overview & Free Real-Time Volume Trigger Notifications - Newser
Measuring HilleVax Inc.’s beta against major indicesWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Evaluating HilleVax Inc. with trendline analysisEntry Point & Safe Entry Momentum Tips - Newser
HilleVax Inc. stock prediction for this weekPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Does HilleVax Inc. show high probability of reboundWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser
Has HilleVax Inc. formed a bullish divergenceJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser
HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF - GlobeNewswire
What momentum shifts mean for HilleVax Inc.Weekly Market Outlook & Low Volatility Stock Suggestions - Newser
Using fundamentals and technicals on HilleVax Inc.Quarterly Trade Summary & Fast Entry Momentum Trade Alerts - Newser
Can swing trading help recover from HilleVax Inc. lossesMarket Movement Recap & Fast Entry Momentum Alerts - Newser
What MACD signals say about HilleVax Inc.2025 Sector Review & Growth Oriented Trade Recommendations - Newser
HilleVax Inc. stock daily chart insightsPortfolio Update Summary & Daily Stock Momentum Reports - Newser
How sentiment analysis helps forecast HilleVax Inc.Market Growth Review & Step-by-Step Trade Execution Guides - Newser
What technical models suggest about HilleVax Inc.’s comebackEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
RSI + MACD Show Convergence for HilleVax Inc.Market Sentiment Review & Daily Price Action Insights - 선데이타임즈
Market reaction to HilleVax Inc.’s recent newsMarket Performance Report & Advanced Technical Analysis Signals - Newser
HilleVax Inc. Stock Performance After Earnings: Historical InsightsNew Guidance & Smart Money Movement Alerts - Newser
How to integrate HilleVax Inc. into portfolio analysis tools2025 Trading Volume Trends & Fast Moving Trade Plans - Newser
Is HilleVax Inc. stock bottoming outJuly 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Has HilleVax Inc. found a price floorJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser
Can volume confirm reversal in HilleVax Inc.2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
Hillevax Inc Stock (HLVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hillevax Inc Stock (HLVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT | See Remarks |
Feb 11 '25 |
Sale |
1.76 |
11,901 |
21,003 |
1,101,498 |
| Maltbie Shane | Chief Financial Officer |
Feb 11 '25 |
Sale |
1.76 |
4,345 |
7,659 |
79,887 |
| Maltbie Shane | Chief Financial Officer |
Feb 04 '25 |
Sale |
1.89 |
3,946 |
7,458 |
84,232 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):